JoseDanielDiazMD

PubMed

• Correlates of concordance between self-reported and lab-confirmed viral load among Black and Latine men who have sex with men (BLMSM) living with HIV in New York City.
  Emily Greene, Melonie Walcott, Lauren Guerra, Hong-Van Tieu, Vijay Nandi, Jorge Soler, Jose Diaz, Frank Curriero, Carl Latkin, Abena Bosompem, Victoria Frye> ;AIDS Care. 2024 May 1
• Endovascular Today: Give Me a Narrowing in the Venous System, and I Shall Stent It
  Maxim E Shaydakov, Jose A Diaz> ;European Journal of Vascular & Endovascular Surgery. 2018 Aug 14
• Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.
  Andraska, E. A.,Luke, C. E.,Elfline, M. A.,Henke, S. P.,Madapoosi, S. S.,Metz, A. K.,Hoinville, M. E.,Wakefield, T. W.,Henke, P. K.,Diaz, J. A.> ;Thromb. Haemost.. 2018 Apr 26
• 13 citations
  Update on the electrolytic IVC model for pre-clinical studies of venous thrombosis
  Olivia R. Palmer, Maxim E. Shaydakov, Joshua Rainey, Daniel A. Lawrence, Joan M. Greve, Jose A. Diaz> ;Research and Practice in Thrombosis and Haemostasis. 2018 Jan 31
• Practice patterns of endovenous ablation therapy for the treatment of venous reflux disease.
  Aziz F, Diaz J, Blebea J, Lurie F> ;J Vasc Surg Venous Lymphat Disord. 2017-01-01
• 1D-(1)H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis.
  Obi, A. T.,Stringer, K. A.,Diaz, J. A.,Finkel, M. A.,Farris, D. M.,Yeomans, L.,Wakefield, T.,Myers, D. D.> ;J Vasc Surg Venous Lymphat Disord. 1900 Jan 01
• Animal models of VT: to change or not to change?
  Diaz JA> ;Blood. 2015-11-05
• P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
  Diaz JA, Wrobleski SK, Alvarado CM, Hawley AE, Doornbos NK, Lester PA, Lowe SE, Gabriel JE, Roelofs KJ, Henke PK, Schaub RG, Wakefield TW, Myers DD> ;Arterioscler. Thromb. Vasc. Biol.. 2015-04-01
• Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.
  English, S. J.,Piert, M. R.,Diaz, J. A.,Gordon, D.,Ghosh, A.,DʼAlecy, L. G.,Whitesall, S. E.,Sharma, A. K.,DeRoo, E. P.,Watt, T.,Su, G.,Henke, P. K.,Eliason, J. L.,Ail...> ;Ann. Surg.. 2014 Mar 22
• Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) model.
  Diaz, J. A.,Farris, D. M.,Wrobleski, S. K.,Myers, D. D.,Wakefield, T. W.> ;J. Thromb. Haemost.. 2015 Feb 17
• Recurrent Deep Venous Thrombosis Is Pathologically Different From Primary Deep Venous Thrombosis: Characterization of the First Mouse Model of Recurrent Venous Thrombo...
  Andraska EA, Henke PK, Luke CE, Elfline MA, Henke SP, Madapoosi SS, Wakefield TW, Diaz JA> ;J Vasc Surg Venous Lymphat Disord. 2015-01-01
• The role of galectin-3 and galectin-3-binding protein in venous thrombosis.
  DeRoo, E. P.,Wrobleski, S. K.,Shea, E. M.,Al-Khalil, R. K.,Hawley, A. E.,Henke, P. K.,Myers, D. D.,Wakefield, T. W.,Diaz, J. A.> ;Blood. 2014 Nov 28
• Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.
  Obi AT, Diaz JA, Ballard-Lipka NL, Roelofs KJ, Farris DM, Lawrence DA, Henke PK, Wakefield TW> ;J Vasc Surg Venous Lymphat Disord. 2014-10-01
• Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
  Obi AT, Diaz JA, Ballard-Lipka NL, Roelofs KJ, Farris DM, Lawrence DA, Wakefield TW, Henke PK> ;J. Thromb. Haemost.. 2014-08-01
• P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution and Prevents Vein Wall Fibrosis Better than Enoxaparin and an Inhibitor to von Willebrand Factor.
  Diaz JA, Wrobleski SK, Pechota AR, Hawley AE, Roelofs KJ, Doornbos NK, Gabriel JE, Reynolds G, Lester P, Londy F, Lowe S, Henke PK, Schaub RG, Wakefield TW, Myers DD> ;J Vasc Surg Venous Lymphat Disord. 2014-01-01
• Plasma DNA is Elevated in Patients with Deep Vein Thrombosis.
  Diaz JA, Fuchs TA, Jackson TO, Kremer Hovinga JA, Lämmle B, Henke PK, Myers DD, Wagner DD, Wakefield TW> ;J Vasc Surg Venous Lymphat Disord. 2013-10-01
• The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.
  Diaz, J. A.,Alvarado, C. M.,Wrobleski, S. K.,Slack, D. W.,Hawley, A. E.,Farris, D. M.,Henke, P. K.,Wakefield, T. W.,Myers, D. D.> ;Thromb. Haemost.. 2013 Apr 11
• Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.
  Patterson KA, Zhang X, Wrobleski SK, Hawley AE, Lawrence DA, Wakefield TW, Myers DD, Diaz JA> ;Thromb. Res.. 2013-03-01
• Vein Wall and Circulating P-selectin Promote Venous Thrombogenesis During Aging in a Rodent Model.
  Myers DD, Culmer D, Diaz J, Hawley A, Jackson T, Shuster K, Sigler R, Wakefield T> ;J Vasc Surg Venous Lymphat Disord. 2013-01-01
• Vitronectin Gene-deletion, PAI-1 Gene-deletion, and LMWH Treatment: Effect on Thrombus Resolution and Vein Wall Remodeling in a Mouse Model of DVT.
  Obi AT, Diaz JA, Farris DM, Roelofs KJ, Ballard-Lipka N, Henke PK, Wakefield TW> ;J Vasc Surg Venous Lymphat Disord. 2013-01-01
• Galectin-3 Binding Protein and Galectin-3: Novel Factors Promoting Venous Thrombosis.
  Diaz JA, Hawley AE, Wrobleski SK, Shea E, DeRoo E, Al-Khalil R, Myers DD, Wakefield TW> ;J Vasc Surg Venous Lymphat Disord. 2013-01-01
• Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model.
  Culmer DL, Diaz JA, Hawley AE, Jackson TO, Shuster KA, Sigler RE, Wakefield TW, Myers DD> ;Thromb. Res.. 2013-01-01
• 43 citations
  The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
  Joe F. Baldwin, Vikram Sood, Megan Elfline, Cathy Luke, Nicholas A. Dewyer, Jose A. Diaz, D.D. Myers, Thomas W. Wakefield, Peter K. Henke> ;Journal of Vascular Surgery. 2012 Oct 1
• Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model.
  Hampton AL, Diaz JA, Hawley AE, Wrobleski SK, Wang J, Lee RD, Kirchhofer D, Sigler RE, Wakefield TW, Mackman N, Myers DD> ;Thromb. Res.. 2012-10-01
• High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.
  Roldán V, Marín F, Díaz J, Gallego P, Jover E, Romera M, Manzano-Fernández S, Casas T, Valdés M, Vicente V, Lip GYH> ;J. Thromb. Haemost.. 2012-08-01
• Join now to see all